HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro susceptibility of Trichosporon beigelii to antifungal agents.

Abstract
The minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFCs) of amphotericin B, flucytosine, miconazole, fluconazole and itraconazole against 21 isolates of Trichosporon beigelii in RPMI-1640 medium were determined using National Committee for Clinical Laboratory Standards (NCCLS) methodology in microdilution method. Most isolates were sensitive to miconazole (MIC90 0.78 microgram/ml), fluconazole (MIC90 6.25 micrograms/ml), and itraconazole (MIC90 0.19 microgram/ml), with the former being the most active agent tested (MFC90 3.12 mu/ml). Although amphotericin B inhibited most strains (MIC range, 0.78-3.12 micrograms/ml), poor fungicidal activity was observed (MFC range, 1.56-12.5 micrograms/ml) showing a pattern of relative resistance in vitro. Flucytosine showed generally poor activity against most isolates tested. These in vitro findings confirm the resistance of T.beigelii to amphotericin B and suggest that azoles may be an alternative to the former for the treatment of disseminated trichosporonosis. However, in vivo studies would better validate these in vitro findings.
AuthorsK Perparim, H Nagai, A Hashimoto, Y Goto, T Tashiro, M Nasu
JournalJournal of chemotherapy (Florence, Italy) (J Chemother) Vol. 8 Issue 6 Pg. 445-8 (Dec 1996) ISSN: 1120-009X [Print] England
PMID8981185 (Publication Type: Journal Article)
Chemical References
  • Antifungal Agents
  • Itraconazole
  • Miconazole
  • Amphotericin B
  • Fluconazole
  • Flucytosine
Topics
  • Amphotericin B (pharmacology)
  • Antifungal Agents (pharmacology)
  • Fluconazole (pharmacology)
  • Flucytosine (pharmacology)
  • Itraconazole (pharmacology)
  • Miconazole (pharmacology)
  • Microbial Sensitivity Tests
  • Trichosporon (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: